Sterling Johnson, PhD, spoke with The New York Times about new blood biomarker tests used to predict a person’s risk of developing Alzheimer’s disease. The tests measure p-tau217, a blood-based biomarker that can detect Alzheimer's disease-related brain changes often years before symptoms appear. He emphasized that healthy lifestyle habits may help protect the brain against the potentially harmful effects of the buildup of Alzheimer's-related proteins.

Nathaniel Chin, MD, and Sterling Johnson, PhD, joined the GeriPal podcast to discuss why dementia in older adults is often more complex than once thought. They explain how newer tests can help identify these different causes of cognitive decline and how this information may influence diagnosis, treatment decisions and the use of emerging Alzheimer’s therapies.

Research by Lindsay Clark, PhD, suggests that simple at-home memory checks conducted on a smartphone or tablet may detect subtle memory loss better than traditional in-clinic assessments. The study included volunteer participants from the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP).

The Wisconsin Alzheimer’s Disease Research Center (ADRC) is excited to share that Rachael Wilson, PhD, has been selected as its newest Developmental Project awardee for her project, “Development of a multiplex immunoassay panel for the detection of Alzheimer's disease and common co-pathologies.”

A new book by Nathaniel Chin, MD, "When Memory Fades: What to Expect at Every Stage, from Early Signs to Full Support for Alzheimer’s and Dementia," offers a clear and compassionate guide for people navigating Alzheimer’s disease and related dementias.

Sterling Johnson, PhD, has been named to Clarivate’s Highly Cited Researchers 2025 list. This honor recognizes researchers whose work has significant and far-reaching influence. Highly Cited Researchers represent just 1 in 1,000 scientists and social scientists worldwide.